Pilot study using Fluorine-18 Sodium Fluoride PET/CT in diagnosing of skeletal metastases in men with prostate cancer.

Recruiting

• Conditions: metastases; spread of cancer; 10027476

• Registration Number: NL-OMON36047
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 90

Inclusion Criteria

De novo prostate cancer, and
Informed consent, and
indication for bone scintigraphy

Exclusion Criteria

oncologic history, and
on hormon treatment, and
unable to tolerate PET/CT

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>1. Discordance and concordance of NaF PET/CT and bone scan.<br /><br>2. Sensitivity and specificity of NaF PET/CT for detection of bonemetastases.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.a.</p><br>